GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samil Pharmaceutical Co Ltd (XKRX:000520) » Definitions » Long-Term Debt

Samil Pharmaceutical Co (XKRX:000520) Long-Term Debt : ₩49,568 Mil (As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Samil Pharmaceutical Co Long-Term Debt?

Samil Pharmaceutical Co's Long-Term Debt for the quarter that ended in Dec. 2023 was ₩49,568 Mil.

Samil Pharmaceutical Co's quarterly Long-Term Debt increased from Jun. 2023 (₩54,895 Mil) to Sep. 2023 (₩68,270 Mil) but then declined from Sep. 2023 (₩68,270 Mil) to Dec. 2023 (₩49,568 Mil).

Samil Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2021 (₩31,911 Mil) to Dec. 2022 (₩71,918 Mil) but then declined from Dec. 2022 (₩71,918 Mil) to Dec. 2023 (₩49,568 Mil).


Samil Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Samil Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samil Pharmaceutical Co Long-Term Debt Chart

Samil Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44,994.32 20,000.00 31,910.51 71,917.50 49,568.46

Samil Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71,917.50 45,755.56 54,895.32 68,269.82 49,568.46

Samil Pharmaceutical Co  (XKRX:000520) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Samil Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Samil Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Samil Pharmaceutical Co (XKRX:000520) Business Description

Traded in Other Exchanges
N/A
Address
990-1, Bangbae-dong, Seocho-Gu, Seoul, KOR, 137-060
Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.

Samil Pharmaceutical Co (XKRX:000520) Headlines

No Headlines